Page 34 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 10 ฉบับที่ 3

184 «“√ “√°“√·æ∑¬å·ºπ‰∑¬·≈–°“√·æ∑¬å∑“߇≈◊Õ° ªï∑’Ë 10 ©∫—∫∑’Ë 3°—𬓬π-∏—𫓧¡ 2555

»÷°…“ ¡’§«“¡·μ°μà“ß°—π¡“°À√◊Õ‰¡à ‡™àπ √–¬– ‡™’¬ß„À¡à ∑’ˉ¥â°√ÿ≥“μ√«®√à“ß·≈–„À⧔·π–π”„π

‡«≈“∑’ˇªìπ‡∫“À«“π Õ“¬ÿ∑’ˇ√‘Ë¡‡ªìπ‡∫“À«“𠇪ìπμâπ °“√¥”‡π‘π°“√«‘®—¬ 𓬷æ∑¬åÕ√√∂ ‘∑∏‘Ï »√’ ÿ∫—μ‘
2. °àÕπ‡≈◊Õ°ºŸâªÉ«¬‡¢â“‚§√ß°“√«‘®—¬ À“°¡’ ®“° ∂“∫—π«‘®—¬·≈–ª√–‡¡‘π‡∑§‚π‚≈¬’∑“ß°“√·æ∑¬å
‡ß‘πß∫ª√–¡“≥‡æ’¬ßæÕ §«√μ√«®Õ“°“√™“¥â«¬ °√¡°“√·æ∑¬å ∑’ˉ¥â°√ÿ≥“„À⧔·π–π”„π°“√ª√–¡«≈

‡§√◊ËÕß EMG (electromyography) ‡æ◊ËÕ„À≥⠺≈°“√«‘®—¬§√—Èßπ’È
¢âÕ¡Ÿ≈√–¥—∫Õ“°“√™“∑’ˇªìπÕ¬Ÿà°àÕπ‡¢â“‚§√ß°“√ ·≈–
μ√«®´È”‡¡◊ËÕ‡ √Á® ‘Èπ‚§√ß°“√ ‡æ◊ËÕ„Àâ “¡“√∂¬◊π¬—π
‰¥âÕ¬à“ß™—¥‡®π«à“ °“√Ωí߇¢Á¡ “¡“√∂≈¥Õ“°“√™“ ‡Õ° “√Õâ“ßÕ‘ß
1. Spruce MC, Potter J, Coppini DV. The pathogenesis and
ª≈“¬ª√– “∑‰¥â
management of painful diabetic neuropathy : a review.
3. §«√¡’°“√μ‘¥μ“¡º≈°“√√—°…“„π√–¬– Diabetes Med 2003;20:88-98.

‡«≈“∑’Ë¡“°°«à“ 2 ‡¥◊Õπ ·≈–·∫àß°≈ÿࡺŸâªÉ«¬μ“¡ 2. Edwards JL, Vineent AM, Cheng HT, Feldman EL. Diabetic
neuropathy: mechanisms to management. Pharmacol Ther
√–¬–¢Õß°“√‡ªìπ‡∫“À«“π ‡æ◊ËÕ„Àâ “¡“√∂∑√“∫‰¥â
2008;120:1-34.
«à“º≈°“√√—°…“¥â«¬°“√Ωí߇¢Á¡®– “¡“√∂™à«¬„ÀâÕ“ 3. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM. Diabetes
Somatic Neuropathies : a technical Review. Diabetes Care
°“√™“¥’¢÷Èπ‡ªìπ‡«≈“π“π‡æ’¬ß„¥ ‡æ◊ËÕª√–‚¬™πå„π
2004;27:1458-68.
°“√«“ß·ºπ°“√√—°…“ºŸâªÉ«¬∑’Ë¡’Õ“°“√™“®“°‡∫“À«“π 4. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes
Metab Res Rev 1999;15:205-18.
„πÕπ“§μ
5. Gales BS, Giamas A, Jensen MP. Painful diabetic
polyneuropathy: epidemiology, pain description, and quality
°‘μμ‘°√√¡ª√–°“» of life. Diabetes Res Clin Pract 2000;47:123-8.
6. Azhary H, Farooq MU, Bhanushali M, Majid A, Kassab
§≥–ºŸâ«‘®—¬¢Õ¢Õ∫§ÿ≥ ·æ∑¬åÀ≠‘ß«‘≈“«—≥¬å MY. Peripheral neuropathy: a nationwide primary care
diabetes clinic-based study. Ann Saudi Med 2007;27:25-
®÷ߪ√–‡ √‘∞ Õ¥’μÕ∏‘∫¥’°√¡æ—≤π“°“√·æ∑¬å·ºπ
31.
‰∑¬·≈–°“√·æ∑¬å∑“߇≈◊Õ° ∑’ˉ¥â„Àâ°“√ π—∫ πÿπ 7. Al-Mahroos F, Al-Roomi K. Diabetic neuropathy, foot
ulceration, peripheral vascular disease and potential risk
®—¥ √√ß∫ª√–¡“≥§à“„™â®à“¬„π°“√¥”‡π‘π°“√«‘®—¬
factors among patients with diabetes in Bahrain: a
§√—Èßπ’È √«¡∑—Èß√à«¡ª√–™ÿ¡„π°“√·≈°‡ª≈’Ë¬π§«“¡ nationalwide primary care diabetes clinic-based study. Ann
§‘¥‡ÀÁπ°—∫ºŸâ‡™’ˬ«™“≠®“°¡À“«‘∑¬“≈—¬°“√·æ∑¬å Saudi Med 2007;27:25-31.
8. ‡§√◊Õ¢à“¬¢âÕ¡Ÿ≈¢à“« “√°“√≈¥ªí®®—¬‡ ’ˬ߇æ◊ËÕªÑÕß°—π
·ºπ®’πÀŸ‡ªÉ¬
§«∫§ÿ¡‚√§‰¡àμ‘¥μàÕ. ‡∫“À«“π°—∫°“√¥Ÿ·≈‡∑â“. ”π—°
¢Õ¢Õ∫§ÿ≥ ”π—°ß“𧫓¡√à«¡¡◊Õ‡æ◊ËÕ°“√ ‚√§‰¡àμ‘¥μàÕ °√¡§«∫§ÿ¡‚√§ °√–∑√«ß “∏“√≥ ÿ¢ [Serial
online] 2006 Oct 5]: [4 Screens] Available from URL:http:/
æ—≤π“√–À«à“ߪ√–‡∑» °√–∑√«ß°“√μà“ߪ√–‡∑» ∑’Ë
/www.tncdreducerisk.com/cms/index.php?option=com_
‰¥â„Àâ°“√ π—∫ πÿπß∫ª√–¡“≥„π°“√‡™‘≠§≥–ºŸâ content& task=view&id=64&itemid=9
9. Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA.
‡™’ˬ«™“≠®“°¡À“«‘∑¬“≈—¬°“√·æ∑¬å·ºπ®’πÀŸ‡ªÉ¬
The health care costs of diabetic peripheral neuropathy in
“∏“√≥√—∞ª√–™“™π®’π ¡“√à«¡„π°“√«‘®—¬§√—Èßπ’È the US. Diabetes Care 2003;26:1790-5.
10. Boulton AJM. Management of diabetic peripheral
¢Õ¢Õ∫§ÿ≥√Õß»“ μ√“®“√¬å𓬷æ∑¬å»ÿ¿π‘¡‘μ
neuropathy. Clinical Diabetes 2005;23:9-15.
∑’¶™ÿ≥‡∂’¬√ ®“°§≥–·æ∑¬»“ μ√å ¡À“«‘∑¬“≈—¬ 11. Schroder S, Liepert J, Remppis A, Greten JH. Acupuncture